Ordeniza, Baby Boy M.
HRN: 24-06-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/17/2023
12/24/2023
IVTT
30mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes